{"disease":{"id":"recurrent-and-refractory-non-hodgkin-s-lymphoma-and-multiple-myeloma","name":"recurrent and refractory non hodgkin s lymphoma and multiple myeloma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05363800","title":"Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":198,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}